Skip to content

Sugar Water injection Versus Steroid Injection in Knee pain

Role of Dextrose Prolotherapy and Methyl Prednisolone Injections in Osteoarthritis Knee

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/09/009735
Enrollment
100
Registered
2017-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Osteoarthritis Knee

Interventions

Intervention1: Dextrose Prolotherapy Group: In group I (Dextrose Prolotherapy Group), patients will receive dextrose prolotherapy in the affected one or both knees. 5ml of 25% Dextrose will be given

Sponsors

Non funded
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged 40-65 years, who has 1. Persisting Knee Pain due to OA Knee (Grade II or III, according to radiological classification of knee OA defined by Kellgren and Lawrence) 2. Pain of at-least 40 mm on a 0-100mm VAS when asked â??What is the average level of your Left/ Right knee pain over the last week?â?? 3. Willing to participate in all assessment 4. If both knees involved, participants choose one or both knees to be treated.

Exclusion criteria

Exclusion criteria: 1. Severe OA Knee (Grade IV , according to Kellgren and Lawrence classification) 2. Inflammatory or post-infectious knee arthritis 3. History of prior knee replacement repair 4. Prior knee Prolotherapy 5. Prior fracture of the knee joint 6. Any Knee injection within 3 months 7. Daily use of opioid medication 8. Other chronic pain diagnoses 9. Diabetes mellitus 10. Body mass index (BMI) > 40 kg/m2 11. H/O Anticoagulation therapy 12. Pregnancy 13. Co-morbidity severe enough to prevent participation in the study protocol including at-home exercise or attendance at scheduled injection appointments.

Design outcomes

Primary

MeasureTime frame
Western Ontario McMaster University Osteoarthritis Index (WOMAC), Knee Injury and Osteoarthritis Outcome Score (KOOS) VAS Scale Goniometric ROM of affected Knee Timepoint: 6 months

Secondary

MeasureTime frame
Injection procedure related pain (0, 2 days after injection) Patient SatisfactionTimepoint: 6 months

Countries

India

Contacts

Public ContactApurba Barman

All India Institute of Medical Sciences Bhubaneswar

apurvaa23@gmail.com9438884211

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026